Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 45 for “"Verteporfin"”.
-
The effects of verteporfin on non-small cell lung cancer
… order to improve the prognosis of this disease. Verteporfin, an FDA approved drug, has recently been reported to downregulate a potential core pathway of NSCLC, the Hippo pathway. The pathway consists of a kinase cascade to control the transcriptional coactivators YAP and TAZ. When these …
-
Φωτοδυναμική θεραπεία ακτινωτού σώματος με verteporfin: πειραματική και κλινική μελέτη
… ciliary body photodynamic treatment with verteporfin (CBPDT) for use in refractory glaucoma cases. Four experiments with rabbits were first performed, to test safety and efficacy of CBPDT. Since all IOP measurements in rabbits were performed with TonoPen-XL under general anesthesia, the …
-
Kurz- und Langzeitergebnisse der Photodynamischen Therapie mit Verteporfin bei altersbedingter Makuladegeneration
… der Photodynamischen Therapie mit Verteporfinbei altersbedingter Makuladegeneration.
-
TARGETING CELLULAR METABOLISM BY LEVERAGING THE PHOTOSENSITIZER VERTEPORFIN TO OVERCOME CANCER MULTIDRUG RESISTANCE
… that photoactivation of the photosensitizer, verteporfin (VP), can directly cause P-gp aggregation due to cross-linking of the protein. Photoactivation of VP resulting in indirect P-gp inhibition, such as by depleting ATP levels, has been understudied. In this context, this thesis aims to …
-
Gezielte photodynamische Therapie mit in kationischen Liposomen enkapsuliertem Verteporfin im Laser-CNV-Mausmodell
… ist die PDT mit dem <br>Photosensibilisator Verteporfin (Visudyne®), welche auf einer phototoxischen Thrombose der CNV-Membranen basiert. <br>Kationische Liposomen sind eine Modifikation konventioneller Liposomen, die aufgrund ihrer positiven Oberflächenladung eine starke Affinität für …
-
Characterization of verteporfin as an inhibitor of autophagosome formation and its therapeutic potential in cancer
… novel inhibitors of autophagosome accumulation. Verteporfin, a benzoporphyrin derivative used in photodynamic therapy, was the only active compound identified. As a photosensitizer, verteporfin generates large amounts of singlet oxygen upon light irradiation, which elicits a cell-death response. …
-
Mass spectrometry and laser photodissociation spectroscopy of gas-phase metalloporphyrin complexes, metalloporphyrin radicals, and Verteporfin
… experiments presented in this thesis focuses on verteporfin (trade name Visudyne), a benzoporphyrin derivative photosensitizer used in photodynamic therapy of the treatment of the wet form of macular degeneration. In this work, the first direct study of its photoproducts and photofragmentation …
-
PREPARATION OF A NANOSUSPENSION OF THE PHOTOSENSITIZER VERTEPORFIN FOR PHOTODYNAMIC AND LIGHT-INDEPENDENT THERAPY IN GLIOBLASTOMA
Photodynamic therapy (PDT) using verteporfin (VP) has treated ocular disease for over 20 years, but recent interest in VP’s light-independent properties has reignited interest in the drug, particularly in glioblastoma (GBM) (NCT04590664). Separate efforts to apply PDT to GBM using 5-aminolevulinic …
-
An Exploration of the Role of Fibronectin in the Anti-Metastatic Properties of Verteporfin in Osteosarcoma
… for additional therapies. Previous work with verteporfin (VP) highlighted its ability to inhibit growth of metastatic K7M2 OS cells alongside an increase in tissue stiffness. Fibronectin (FN1) was investigated as a mediator of this effect via analysis of K7M2 cells following VP treatment. This …
-
Funktionelle Ergebnisse und Nebenwirkungen der Photodynamischen Therapie mit Verteporfin bei der Behandlung des Hämangioms der Aderhaut
… mittels Photodynamischer Therapie mit Verteporfin (Visudyne®, Novartis, Bülach, CH) zeigte in unserer Arbeit insgesamt gute Ergebnisse im Hinblick auf die Reduktion der Tumorprominenz, den Visusverlauf und die Rückbildung der subretinalen Flüssigkeit sowie der Exsudation. Nach einer …
-
Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin
… benzoporphyrin derivative monoacid ring A (BPD) verteporfin which absorbs strongly at 690 nm, on murine skin allograft rejection was tested using a unique approach. Skin sections (C57BL/6)were exposed in vitro to varying doses of BPD (0.125 - 1.0 μg/mL) and 10 J/cm² light at a wavelength of 690 …
-
A Pilot Investigation on Immunogenic Cell Death Induction by Verteporfin-Photodynamic Therapy in Metastatic Murine Osteosarcoma Cells
… highlighting the need for alternative therapies. Verteporfin (VP)-photodynamic therapy (PDT) shows promise due to VP's ability to inhibit the transcriptional co-activator yes-associated protein (YAP) and affect the tumour microenvironment. I hypothesized that VP modulates the immune tumour …
-
Local photodynamic therapy for equine squamous cell carcinoma in a murine model
… groups received intra-tumoral injection of verteporfin at a dose of 0.01, 0.1 or 1.0 mg/cm3 dissolved in DMSO. Controls received only DMSO or no injectate. In study 2 (solvent effect), two treatment groups received verteporfin (0.1mg/cm3) dissolved in 5% dextrose solution (D5W) or DMSO. …
-
Hypoxia in gliomas: a pathogenic driver and therapeutic opportunity
… gliomas and thus the effect of YAP inhibitor, verteporfin was investigated. Treatment of primary and immortalised glioma cell lines with verteporfin resulted in cell death but strikingly only under hypoxic conditions (1% O2). This investigation discovered that cell death occurs through a …
-
Non-invasive imaging of lymphatic remodeling in response to injury through photodynamic therapy
… system. Recently, it has been shown that verteporfin, a photosensitive drug widely used for photodynamic therapy (PDT) to ablate the blood vessels, provides a similar effect on lymphatic vessels. Here, we seek to administer verteporfin and perform PDT of collecting lymphatics in the mouse …
-
Connecting the Dots: A Multi-Approach Investigation to Identify New Molecular Targets for Canine Osteosarcoma
… study explored the use of the YAP inhibitor, verteporfin, for the treatment of advanced disease and characterized its impact on the lung microenvironment throughout metastasis development. This study found that the lung’s innate immune cells increase throughout metastatic progression, while …
-
Multi-Functional Polymer Vesicles: Applications in Chemotherapy and Photodynamic Therapy
… an existing photosensitizer formulation called verteporfin that is currently used in the clinic for age-related macular degeneration (AMD). The polymersome formulation outperformed verteporfin both at the in vitro and in vivo level. Additionally, we investigated the photorupture of giant …
Page 1 of 3